ArticleFrontiers in pharmacology2022

SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor.

Tingting Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.